Skip to main content
TipRanks
Go Ultimate75% OFF

Tempest Therapeutics (TPST) Q4 2021 Earnings Report

1,276 Followers

TPST Q4 2021 EPS Results

Actual EPS
-$14.56
Consensus EPS
-$16.03
Beat/Miss
Beat by +$1.47
One Year Ago EPS
-$74.10

TPST Q4 2021 Revenue Results

Actual Revenue
$0
Expected Revenue
$0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q4 2021
Date
03/29/2022
Time
After Close
Conference Call
Tuesday, March 29, 2022
TPST Upcoming Earnings

Tempest Therapeutics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.

Q4 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

TPST Earnings History

TPST earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 31, 20272026 (Q4)―--0.31――
Nov 11, 20262026 (Q3)-0.32--0.79―
Aug 13, 20262026 (Q2)-0.30-0.34-2.0783.57% (+1.73)
May 14, 20262026 (Q1)-0.28-2.53-3.1619.94% (+0.63)
Mar 30, 20262025 (Q4)-0.62-0.31-4.0392.31% (+3.72)
Nov 05, 20252025 (Q3)-3.27-0.79-5.3385.18% (+4.54)
Aug 11, 20252025 (Q2)-3.23-2.07-5.4662.09% (+3.39)
May 13, 20252025 (Q1)-3.29-3.16-4.6832.48% (+1.52)
Mar 27, 20252024 (Q4)-3.27-4.03-4.9418.42% (+0.91)
Nov 12, 20242024 (Q3)-4.71-5.33-6.2414.58% (+0.91)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed